Relypsa, Inc. Files $126.5 Million IPO

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Relypsa, Inc. filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $126.5 million. The company plans to trade on teh Nasdaq Global Market. The offering is being made via Morgan Stanley, BofA Merrill Lynch, Cowen and Company, Stifel, and Wedbush PacGrow Life Sciences.

Help employers find you! Check out all the jobs and post your resume.

Back to news